US equities |
MU $1,045.56 ▲+0.00% INTC $112.50 ▲+0.00% NVDA $239.24 ▲+0.00% AMD $649.42 ▲+0.00% SNDK $1,660.46 ▲+0.00% SPCX $171.92 ▲+0.00% MRVL $287.01 ▲+0.00% GOOG $344.59 ▲+0.00%
FinancialContent

Latest News about Phase 3 Clinical Trial

Recent news which mentions Phase 3 Clinical Trial

UK Supports Psychedelic Research With Phase 3 Trial In Federal Health Sites
Tickers AWKNF
Tags Penny Stocks Psychedelics UK National Health Service
From Benzinga
MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next
Tags FDA News Benzinga
From Benzinga
Compass Pathways Will Lead Two Concurrent Phase 3 Trials On Psilocybin-Assisted Therapy For Depression
Tickers CMPS
Tags Markets Phase 3 Clinical Trial Market News
From Benzinga